Overview
Updated 14 Jul 2026
Peter Izmirly, MD, is Professor, Department of Medicine, NYU Grossman School of Medicine. The public record shows 214 publications with 12,218 citations (h-index 49), centered on Lupus (SLE). It also documents an investigator role on 1 registered clinical trials, industry payments reported by 1 companies, 4 NIH-funded awards (2017–2025).
- Most recent indexed publication: 2026 · Lupus science & medicine
- Top research focus: Lupus (SLE)
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 23 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Sponsor: NYU Langone Health
InvestigatorPhase 3RecruitingNCT05799378
Industry payments
Updated 14 Jul 2026
1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20211 payment
NIH funding
Updated 14 Jul 2026
4 NIH research awards on record, funded 2017–2025 per NIH RePORTER. The latest:
- DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health
New York University School of Medicine
FY2025$899,999U01DP006700 - Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
New York University School of Medicine
FY2024$1,308,540R01AR082149 - DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health
New York University School of Medicine
FY2024$950,000U01DP006700
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Children exposed to hydroxychloroquine in utero show no signs of retinal toxicity at age 5.
Lupus science & medicine
2026 - Transcription factor Etv3 controls the tolerogenic function of dendritic cells.
Science (New York, N.Y.)
2026 - A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis.
The Journal of experimental medicine
2025 - A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus erythematosus patients.
Rheumatology (Oxford, England)
2025 - Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.
Rheumatology (Oxford, England)
2025
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
550 First Avenue, 6th Floor, MSB 625, New York, NY 10016
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.nyu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.nyu.edu ↗
- Co-Director
NYU Lupus Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.nyu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.nyu.edu ↗
Media & interviewspress, podcasts and appearances
- Medscape InDiscussion podcast
"Lupus by the Numbers: What the Data Reveals" (Episode 1) - discussed SLE epidemiology as NYU Grossman School of Medicine professor and NYU Lupus Clinic co-director
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗ - Lupus Foundation of America "The Expert Series" podcast episode on Lupus and Fibromyalgia
featured alongside Dr. Kelly Corbitt
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/peter-izmirly-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
medscape.com/viewarticle/1002123
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗ - Spotify
creators.spotify.com/pod/profile/lupus-org/episodes/The-Expert-Series-S8E1-Lupus-and-Fibromyalgia-e2te7ga
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →creators.spotify.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Nathan Levin, MD
NYU School of Medicine
- 822
- publications
- 88
- h-index
- 7
- trials
Lenard Adler, MD
NYU School of Medicine
- 318
- publications
- 60
- h-index
- 10
- trials